Baltimore Preakness announced today that it will allow Kentucky Derby champion Medina Spirit (Medina Spirit) to participate in Saturday’s game, but will undergo a series of additional tests.
In the days leading up to the second round of the Triple Crown, the other two horses trained by Medina Spirit and Bob Buffett will be reviewed. The Maryland Equestrian Commission and Buffett have reached a consensus on the conditions of the Medina Spirit competition. The concert tour (also listed as “Preakness”) and the “Preakness” have also reached consensus, the latter will participate on Friday Another game.
The Medina Spirit will be ranked third out of 10 horses and will be 9-5 as the top seed. The tour will start on the 10th and will be ranked second in 5-2 betting.
Earlier in the day, Bavert explained that Medina Spirit was treated with an anti-fungal ointment containing the steroid betamethasone, which may make the racehorse tested positive for anti-stimulants after the race.
Bavert said in a statement issued by his lawyer that the spirit of Medina received daily treatment before the game on May 1. The ointment was used to treat dermatitis, and equine drug experts said this could explain the results.
Baffert said that the Pony content of this substance in the foal is 21 picograms, which is positive, and it is against the rules to usually provide this drug to the horse to help the joints.
Regardless of the reason, if the second round of testing still shows betamethasone, Medina Spirit may be disqualified from the derby and Mandalen will be declared the winner.
Buffett said: “My research is still going on. We can’t determine whether the ointment is the cause of the result or whether the result is accurate, because they still need a second sample to confirm.
At a press conference held in Churchill Downs on Sunday, Buffett stated that he did not know how the substance entered the pony system.